One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment

Overview of attention for article published in Stem Cell Research & Therapy, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 6,338 followers.

Mesenchymal Stem Cell Therapy (MSCT) can help Post Severe Covid. https://t.co/iRBzfo57Fj Also... 'Review of the potential of mesenchymal stem cells for the treatment of infectious diseases'. https://t.co/RV8IxYE7SC Could it benefit ME? Maybe a few res

15 Apr 2023

Reply Repost Favourite

RT @Jenn030303: One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment…

17 Nov 2022

Reply Repost Favourite

One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment https://t.co/ZbOEA4IpDS

11 Nov 2022

Reply Repost Favourite

6,160/ China (est. current tobacco smoking age 15+ was 25.3% in 2020) Of 25 still alive 1 year after being hospitalized with severe Covid-19, 28% were smokers (not specified if current or ever) https://t.co/ZjKb0G5YiW

19 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.